Distinct inflammatory patterns and nasal bacterial dysbiosis in uncontrolled chronic rhinosinusitis.

Eur Arch Otorhinolaryngol

Department of Otolaryngology, Peking University Third Hospital, Haidian District, No. 49 Huayuan North Road, Beijing, 100191, People's Republic of China.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: The concept of disease control is increasingly gaining importance in the long-term management of chronic rhinosinusitis (CRS). Eosinophilic inflammation has been identified as a high-risk factor for uncontrolled CRS. Although evidence suggests that dysbacteriosis is involved in the pathogenesis of eosinophilic CRS, its association with disease control has not been explored. We attempt to explore the inflammatory patterns and nasal bacterial dysbiosis among patients with uncontrolled CRS.

Methods: We performed a cross-sectional study of 48 patients with uncontrolled CRS, 44 patients with controlled CRS, and 58 healthy controls. Uncontrolled CRS was defined according to European Position Paper on Rhinosinusitis and Nasal Polyps 2020. The nasal mucus and peripheral venous blood were collected for inflammatory endotype analysis. The bacterial microbiota of the swab from the middle meatus was profiled by sequencing the V3-V4 region of the 16S rRNA gene.

Results: Uncontrolled CRS showed significantly higher levels of mucus eosinophil-derived neurotoxin (EDN) (P < 0.001), blood eosinophil counts (P = 0.002), blood basophil counts (P = 0.020), and blood lymphocyte counts (P = 0.033) than patients with controlled CRS. The nasal mucus EDN level was the best predictor of uncontrolled CRS, with the highest area under the receiver operating characteristic curve (AUC) of 0.798 (95% confidence interval [CI] = 0.692-0.904) compared to other inflammatory parameters. Patients with uncontrolled CRS exhibited a significant increase in the abundance of seven genera. Except for Ralstonia and Acinetobacter, the other five genera had a mean relative abundance < 1%, including Klebsiella and Pseudomonas. By random forest analysis, we established a model for the nasal microbiome with an AUC of 0.949 (95% CI = 0.903-0.996). Upon incorporating peripheral eosinophil and basophil counts into the model, we found an enhancement in diagnostic capability, with an AUC of 0.974 (95% CI = 0.944-1.000).

Conclusions: Patients with uncontrolled CRS have distinct local and systematic inflammatory patterns and bacterial dysbiosis compared to both controlled CRS and healthy controls, which sheds light on the pathogenesis of uncontrolled status in CRS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-025-09376-yDOI Listing

Publication Analysis

Top Keywords

uncontrolled crs
24
patients uncontrolled
12
crs
10
inflammatory patterns
8
patterns nasal
8
nasal bacterial
8
bacterial dysbiosis
8
uncontrolled
8
chronic rhinosinusitis
8
disease control
8

Similar Publications

Background: Anosmia is a common, debilitating, and often treatment-resistant symptom of CRS. Biological therapies are a novel and promising treatment for severe and uncontrolled CRS, however, the impact of biological therapy specifically on olfatory dysfunction has not yet been evaluated through systematic review.

Methodology: Systematic searches of Ovid MEDLINE, EMBASE and Cochrane Library were performed on 25/05/2024, assessing olfactory outcomes following treatment with biologics.

View Article and Find Full Text PDF

Long-term clinical control in chronic rhinosinusitis: Outcomes more than five years after surgery.

Eur Arch Otorhinolaryngol

August 2025

Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Purpose: Chronic rhinosinusitis (CRS) is a common chronic and disabling disease with a high socioeconomic burden. The primary goal of treatment is improving health-related quality of life (HRQoL) and maintaining clinical control. The aim of this study was to assess clinical control in CRS patients more than 5 years after endoscopic endonasal surgery (EES).

View Article and Find Full Text PDF

Background: Omalizumab has demonstrated efficacy in treating chronic rhinosinusitis (CRS) with nasal polyps and comorbid asthma (NPwAS) in preoperative settings. However, real-world evidence regarding its postoperative application remains limited. This study aimed to assess the effectiveness and safety of omalizumab in managing NPwAS following endoscopic sinus surgery (ESS), and to identify predictors for treatment response.

View Article and Find Full Text PDF

Objective: Asthma (AS) and allergic rhinitis (AR) are the two most common comorbidities for chronic rhinosinusitis with nasal polyps (NP). This study aims to compare the different impacts of AS and AR on NP, including disease severity, inflammatory profiles, and surgical outcomes.

Methods: The retrospective study enrolled NP patients who underwent endoscopic sinus surgery and 12 months follow-up.

View Article and Find Full Text PDF

Introduction: The histopathologic study of nasal polyps establishes endotype features of chronic rhinosinusitis (CRS). A tissular eosinophil count greater than 10 per high power field (HPF) classifies this condition as type 2 inflammation. Blood and mucosal eosinophils are suggested as biomarkers of severity and control of CRS.

View Article and Find Full Text PDF